|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Serum IGF-1 is insufficient to restore skeletal size in the total absence of the growth hormone receptor显示文摘 | Wu Y Sun H Basta-Pljakic J Cardoso L Kennedy OD Jasper H Domene H Karabatas L Guida C Schaffler MB Rosen CJ Yakar S | | 0，，： | 1 |
| 2 | Regulation of milk protein gene expression 显示文摘 | ROSEN J M WYSZOMIERSKI S L HADSELL D | 1999 | Annual Review of Nutrition1999，19，： | 1 |
| 3 | Long-term efficacy and safety of zoledronic acid compared with pamidronate disodium in the treatment of skeletal complications in patients with advanced multiple myeloma or breast carcinoma: a randomized, double-blind, multicenter, comparative trial显示文摘 | GORDON D KAMINSKI M | 2003 | Cancer2003，98，8： | 1 |
| 4 | Formulation and Solving Paramentric Design Problems Involving Non-Interference Contrains显示文摘 | Coulter S L Bras B A Rosen D W | 1997 | Engineering with Computer1997，，13： | 1 |
| 5 | Broad clinical activity of zoledronic acid in osteolytic to oste0blastie bone lesions in pa tients with a broad range of solid tumors显示文摘 | Rosen L Harland S J Oosterlinck W | 2002 | Am J Clio Oncol2002，25，61： | 1 |
| 6 | Homing endonuclease I-CreI derivatives with novel DNA target specificities显示文摘 | ROSEN L E MORRISON H A MASRI S | 2006 | Nucleic AcidsResearch2006，34，17： | 1 |
| 7 | A phase I first-in-human study of TRC105 (anti-endoglin anti-body) in patients with advanced cancer显示文摘 | ROSEN L S HURWITZ H I WONG M K | 2012 | Clin Cancer Res2012，18，17： | 1 |
| 8 | Zoledronic acid is superior to pamidronate for the treatment of bone metastases in breast carcinoma patients with at least one osteolytic lesion显示文摘 | ROSEN L S GORDON D H DUGAN W J | | 0，，01： | 1 |
| 9 | Lindau' s Disease:Review of the Literature and Study of a Large Kindred 显示文摘 | Melnon K L Rosen S W | 1964 | Am J Med1964，36，： | 1 |
| 10 | Association between prostate cancer and serum testosterone levels 显示文摘 | Zhang P L Rosen S Veeramachaneni R | 2002 | Prostate2002，53，3： | 1 |
| 11 | Free radicals and phagocytic cells显示文摘 | Rosen G M Pou S Ramos C L | 1995 | The FASEB Journal1995，9，2： | 1 |
| 12 | Long-term efficacy and safety of zoledronic acid in the treatment of skeletal metastases in patients with non-small cell lung carcinoma and other solid tumors: a randomized,PhaseⅢ ,double blind,placebo-controlled trial显示文摘 | Rosen L S Gordon D Tehekmedyian N S Yanagihara R Hirsh V Krzakowski M | 2004 | Cancer2004，100，： | 1 |
| 13 | Fasei ocular arrangement in partial Oculomotor paresjs显示文摘 | Ksiazek S M Slamovits T L Rosen C E | 1994 | Am J Ophthalmocacel1994，118，： | 1 |
| 14 | Psammotoid ossifying fibroma of the ethmoid sinus 显示文摘 | Rosen C A Cohe J L Coal F S | 1992 | Arch Otolaryngol Head Neck Surg1992，118，10： | 1 |
| 15 | Long-term efficacy and safety of zoledronic acid compared with pamidronate disodium in the treatment of skeletal complications in patients with advanced multiple myeloma or breast carcinoma显示文摘 | Rosen L S Gordon D Kaminski M | 2003 | Cancer2003，98，： | 1 |
| 16 | Regulation of milk protein gene expression显示文摘 | ROSEN J M WYSZOMIERSKI S L HADSELL D | 1999 | Annu Rev Nutr1999，19，： | 1 |
| 17 | A first-in-human phase Istudy of the CDK4/6 inhibitor, LY2835219, for patients with advancedcancer显示文摘 | Shapiro G Rosen L S Tolcher A W | 2013 | ASCO Meeting Abstracts2013，31，15： | 1 |
| 18 | LY2835219, a novel cellcycle inhibitor selective for CDK4/6, in combination with fulvestrant forpatients with hormone receptor positive (HR+) metastatic breast cancer显示文摘 | Patnaik A Rosen L S Tolaney S M | 2014 | ASCO Meeting Abstracts2014，32，15： | 1 |
| 19 | Regulation of milk protein gene expression显示文摘 | ROSEN J M WYSZOMIERSKI S L HADSELL D | 1999 | Annu Rev Nutr1999，19，： | 1 |
| 20 | A phase I study evalu ating the effect of CDHP as a component of S- 1 on the phar macokinetics of 5 - fluorouracil显示文摘 | Saif M W Rosen L S Saito K | 2011 | Anticancer Res2011，31，2： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员